Fund+
Overview
Fund+ invests in life sciences companies in Belgium.
Investment Focus
- Active in life sciences (primary focus on therapeutics, not excluding diagnostics and medical devices)
- In an advanced development stage (first round and subsequent financing)
- Experienced management team respecting highest ethical values
- Solid business plan
- Invest in Europe, with a focus on Belgium
Portfolio Companies
TubulisOna TherapeuticsIndigo DiabetesTargED BiopharmaceuticalsAstriVaxMinoryx TherapeuticsCardior PharmaceuticalsHoramaAelin Therapeutics
Reach Fund+ directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Fund+
What sectors does Fund+ invest in?
Fund+ invests in Life Sciences, Digital Health, Medical Devices, Diagnostics and Biotechnology, and is based in Flemish Brabant, Belgium. Fund+ is listed as a vc in the ConnectSafely investor database.
What stage does Fund+ invest at?
Fund+ backs companies at Series A and Series B, writing cheques of 5M - 15M.
Which regions does Fund+ invest in?
Fund+ invests across Germany, France, Spain and Belgium.
What companies has Fund+ invested in?
Fund+'s portfolio includes Tubulis, Ona Therapeutics, Indigo Diabetes, TargED Biopharmaceuticals, AstriVax, Minoryx Therapeutics, Cardior Pharmaceuticals and Horama.
Last updated · Source: ConnectSafely investor database
